Transforming growth factor-alpha targeting molecule

Transforming growth factor-alpha targeting molecule has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 12, 2023: “Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: Role of transforming growth factor-alpha”.

Intervention

1 paper studies it3 findingsUpdated

  • 1 lab in 1 country
  • Funder: Agencia Estatal de Investigación
  • Animals1

What did studies of Transforming growth factor-alpha targeting molecule find?

3

Studies of Transforming growth factor-alpha targeting molecule measured 3 outcomes; the most studied are TGFA (1 study), neurogenesis (1) and cognitive function (1).

TGFA

upin mice1

1 study
  1. Transforming growth factor-alpha targeting molecule increases TGFA in mice.

    “This compound facilitates the release of TGFα in vitro and in vivo and activates signaling pathways initiated by this growth factor.”

    Animalsin vitro and in vivo

    Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: Role of transforming growth factor-alpha

    Aging cell

More on TGFA

Neurogenesis

upin mice1

1 study
  1. Transforming growth factor-alpha targeting molecule increases neurogenesis in mice.

    “positively regulating neurogenesis and improving cognitive performance.”

    Animalsin SAMP8 mice

    Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: Role of transforming growth factor-alpha

    Aging cell

Cognitive function

upin mice1

1 study
  1. Transforming growth factor-alpha targeting molecule improves cognitive function in mice.

    “treatment of SAMP8 mice with a transforming growth factor-alpha (TGFα) targeting molecule prevents the observed defects, positively regulating neurogenesis and improving cognitive performance.”

    Animalsin SAMP8 mice

    Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: Role of transforming growth factor-alpha

    Aging cell

Latest